TNGX Tango Therapeutics, Inc. - Common Stock
$26,08
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$6–$34
70% of range
Analystenbewertung
BUY
19 analysts
Kursziel
$44
+70% upside
P/E (TTM)
-30.0
ROE
-42.2%
Nettogewinnmarge
-162.8%
Über Tango Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
TNGX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$26.07
Marktkapitalisierung
$3.54B
P/E (TTM)
-30.0
EPS (TTM)
$-0.87
Umsatz (TTM)
$62M
Dividendenrendite
—
ROE
-42.2%
Verschuldungsgrad
—
52W-Spanne
$6 – $34
TNGX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$62M
2020-12-31
→
2025-12-31
EPS
$-0.87
2021-12-31
→
2025-12-31
Freier Cashflow
$-140M
2021-12-31
→
2025-12-31
Margen
-162.8%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TNGX
Peer-Median
P/E (TTM)
-30.0
13.2
P/S (TTM) (K/V (TTM))
56.8
55.3
P/B (K/B)
10.2
3.5
Price / FCF (Kurs / FCF)
-25.3
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TNGX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-178.4%
—
Net Profit Margin (Nettogewinnmarge)
-162.8%
-151.2%
ROA
-28.4%
-42.2%
ROE
-42.2%
-52.8%
ROIC
-32.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TNGX
Peer-Median
Current Ratio (Liquiditätsgrad)
16.3
10.3
Quick Ratio
15.8
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TNGX
Peer-Median
Revenue YoY (Umsatz YoY)
48.3%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
35.9%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
52.1%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TNGX
Peer-Median
TNGX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
19 Analysten
- Starker Kauf 8 42,1%
- Kauf 9 47,4%
- Halten 2 10,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-13
Median
$40.00
Mittelwert
$44.33
Jetzt
$26.07
Tief
$24.00
Hoch
$69.00
Median-Ziel
$40.00
+53,4%
Mittelwert-Ziel
$44.33
+70,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.05%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.32 | $-0.32 | -0.00% |
| 31. Dezember 2025 | $-0.29 | $-0.33 | 0.04% |
| 30. September 2025 | $0.14 | $-0.05 | 0.19% |
| 30. Juni 2025 | $-0.35 | $-0.35 | 0.00% |
| 31. März 2025 | $-0.36 | $-0.36 | -0.00% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| PBLS | — | — | — | — | — | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
| LEGN | — | — | — | — | — | — |
| DNLI | $2.58B | -5.6 | 204.7% | — | -50.2% | — |
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $62M | $42M | $37M | $25M | $37M | $8M | |
| R&D Expense | $132M | $144M | $115M | $106M | $78M | $50M | |
| SG&A Expense | $42M | $44M | $36M | $30M | $18M | $10M | |
| Operating Expenses | $174M | $188M | $151M | $136M | $95M | $60M | |
| Operating Income | $-111M | $-146M | $-114M | $-111M | $-58M | $-52M | |
| Other Non-op | $4M | $8M | $6M | $1M | $-248.0K | $120.0K | |
| Pretax Income | $-102M | $-130M | $-102M | $-108M | $-58M | $-52M | |
| Income Tax | $4.0K | $208.0K | $134.0K | $54.0K | $292.0K | $0 | |
| Net Income | $-102M | $-130M | $-102M | $-108M | $-58M | $-52M | |
| EPS (Basic) | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | · | |
| EPS (Diluted) | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | · | |
| Shares (Basic) | 116,166,187 | 109,226,731 | 94,572,448 | 87,820,037 | 62,108,032 | · | |
| Shares (Diluted) | 116,166,187 | 109,226,731 | 94,572,448 | 87,820,037 | 62,108,032 | · | |
| EBITDA | $-111M | $-146M | $-114M | $-111M | $-58M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112M | $70M | $66M | $60M | $143M | $28M | |
| Short-term Investments | $231M | $188M | $270M | $306M | $343M | $162M | |
| Receivables | · | · | · | $2M | $2M | $2M | |
| Prepaid Expense | $10M | $8M | $9M | $7M | $5M | $1M | |
| Current Assets | $354M | $266M | $347M | $375M | $492M | $194M | |
| PP&E (Net) | $7M | $8M | $10M | $11M | $5M | $4M | |
| PP&E (Gross) | $17M | $16M | $16M | $15M | $7M | $6M | |
| Accum. Depreciation | $11M | $8M | $6M | $4M | $3M | $2M | |
| Other Non-current Assets | $303.0K | $4.0K | $46.0K | $5.0K | $19.0K | $38.0K | |
| Total Assets | $399M | $316M | $403M | $436M | $500M | $207M | |
| Accounts Payable | $1M | $2M | $3M | $4M | $3M | $2M | |
| Accrued Liabilities | · | · | · | · | · | $74.9K | |
| Current Liabilities | $22M | $38M | $46M | $56M | $41M | $41M | |
| Capital Leases | $31M | $34M | $37M | $39M | · | $7M | |
| Other Non-current Liabilities | · | · | · | · | · | $5.0K | |
| Total Liabilities | $53M | $117M | $149M | $187M | $155M | $169M | |
| Common Stock | $136.0K | $108.0K | $102.0K | $88.0K | $88.0K | $40.0K | |
| Paid-in Capital | $949M | $701M | $624M | $523M | $507M | $142M | |
| Retained Earnings | $-603M | $-502M | $-371M | $-270M | $-161M | $-103M | |
| AOCI | $224.0K | $336.0K | $186.0K | $-4M | $-765.0K | $17.0K | |
| Stockholders' Equity | $346M | $200M | $253M | $249M | $345M | $39M | |
| Liabilities + Equity | $399M | $316M | $403M | $436M | $500M | $207M | |
| Shares Outstanding | 135,940,454 | 107,729,343 | 102,202,759 | 88,179,374 | 87,598,184 | 40,372,133 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $26M | $29M | $19M | $14M | $8M | $2M | |
| Operating Cash Flow | $-139M | $-132M | $-118M | $-109M | $-60M | $70M | |
| CapEx | $1M | $754.0K | $2M | $8M | $2M | $1M | |
| Investing Cash Flow | $-41M | $86M | $41M | $26M | $-183M | $-145M | |
| Financing Cash Flow | $222M | $48M | $82M | $2M | $357M | $81M | |
| Net Change in Cash | $43M | $2M | $6M | $-81M | $114M | $5M | |
| Taxes Paid | $12.0K | · | · | · | · | · | |
| Free Cash Flow | $-140M | $-132M | $-120M | $-117M | $-61M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% | · | |
| Net Margin | -162.8% | -309.7% | -278.5% | -435.1% | -157.2% | · | |
| Pretax Margin | -162.8% | -309.2% | -278.2% | -434.9% | -156.4% | · | |
| EBITDA Margin | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% | · | |
| ROA | -28.4% | -36.2% | -24.2% | -23.1% | -16.5% | · | |
| ROE | -42.2% | -60.8% | -38.4% | -41.4% | -16.4% | · | |
| ROIC | -32.1% | -73.1% | -45.2% | -44.5% | -17.0% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | 7.0 | 7.5 | 6.8 | 12.1 | 13.1 | |
| Quick Ratio | 15.8 | 6.8 | 7.3 | 6.6 | 12.0 | 11.5 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | · | · | 12.4 | 18.5 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.3% | 15.2% | 46.9% | -32.9% | 383.8% | · | |
| Revenue CAGR 3Y | 35.9% | 4.3% | 68.3% | · | · | · | |
| Revenue CAGR 5Y | 52.1% | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $62M | $42M | $37M | $25M | $37M | $8M | |
| Net Income TTM | $-102M | $-130M | $-102M | $-108M | $-58M | $-52M | |
| Market Cap | $1.20B | $333M | $1.01B | $639M | $958M | $65M | |
| P/E | -10.2 | -2.6 | -9.2 | -5.9 | -11.6 | · | |
| P/S | 19.3 | 7.9 | 27.7 | 25.7 | 25.9 | 8.4 | |
| P/B | 3.5 | 1.7 | 4.0 | 2.6 | 2.8 | 12.9 | |
| P / Tangible Book | 3.5 | 1.7 | 4.0 | 2.6 | 2.8 | 1.7 | |
| P / Cash Flow | -8.7 | -2.5 | -8.6 | -5.9 | -16.1 | · | |
| P / FCF | -8.6 | -2.5 | -8.5 | -5.5 | -15.6 | · | |
| Earnings Yield | -9.8% | -38.5% | -10.9% | -17.0% | -8.6% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $54M | $3M | $5M | $4M | $12M | $20M | $6M | $5M | $11M | $15M | $6M | $6M | $7M | |
| R&D Expense | $37M | $34M | $32M | $31M | $33M | $36M | $34M | $33M | $39M | $38M | $31M | $27M | $29M | $28M | $29M | $29M | |
| SG&A Expense | $23M | $15M | $10M | $9M | $11M | $11M | $11M | $11M | $11M | $11M | $9M | $9M | $9M | $8M | $8M | $8M | |
| Operating Expenses | $60M | $49M | $42M | $40M | $44M | $48M | $45M | $44M | $49M | $49M | $40M | $36M | $38M | $36M | $37M | $37M | |
| Operating Income | $-60M | $-49M | $-42M | $14M | $-41M | $-43M | $-41M | $-33M | $-30M | $-42M | $-35M | $-26M | $-23M | $-30M | $-31M | $-30M | |
| Other Non-op | $722.0K | $1M | $1M | $705.0K | $910.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $967.0K | $523.0K | |
| Pretax Income | $-55M | $-46M | $-39M | $16M | $-39M | $-40M | $-38M | $-29M | $-25M | $-38M | $-31M | $-22M | $-21M | $-28M | $-29M | $-29M | |
| Income Tax | $1.0K | $1.0K | $-55.0K | $-10.0K | $35.0K | $34.0K | $49.0K | $54.0K | $65.0K | $40.0K | $47.0K | $23.0K | $64.0K | $0 | $51.0K | $0 | |
| Net Income | $-55M | $-46M | $-39M | $16M | $-39M | $-40M | $-38M | $-29M | $-26M | $-38M | $-31M | $-22M | $-21M | $-28M | $-29M | $-29M | |
| EPS (Basic) | $-0.37 | $-0.32 | $-0.30 | $0.14 | $-0.35 | $-0.36 | $-0.33 | $-0.27 | $-0.24 | $-0.35 | $-0.30 | $-0.23 | $-0.23 | $-0.32 | $-0.33 | $-0.33 | |
| EPS (Diluted) | $-0.37 | $-0.32 | $-0.29 | $0.13 | $-0.35 | $-0.36 | $-0.33 | $-0.27 | $-0.24 | $-0.35 | $-0.30 | $-0.23 | $-0.23 | $-0.32 | $-0.33 | $-0.33 | |
| Shares (Basic) | 149,875,939 | 143,576,292 | -215,642,250 | 110,966,345 | 110,540,836 | 110,301,256 | -215,766,401 | 108,507,390 | 108,314,279 | 108,171,463 | -179,009,332 | 97,033,273 | 88,354,590 | 88,193,917 | -175,582,615 | 87,892,195 | |
| Shares (Diluted) | 149,875,939 | 143,576,292 | -222,457,979 | 117,782,074 | 110,540,836 | 110,301,256 | -215,766,401 | 108,507,390 | 108,314,279 | 108,171,463 | -179,009,332 | 97,033,273 | 88,354,590 | 88,193,917 | -175,582,615 | 87,892,195 | |
| EBITDA | $-60M | $-49M | · | $14M | $-41M | $-43M | · | $-33M | $-30M | $-42M | · | $-26M | $-23M | $-30M | · | $-30M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $346M | $158M | $112M | $58M | $39M | $58M | $70M | $53M | $52M | $61M | $66M | $59M | $66M | $57M | $60M | $100M | |
| Short-term Investments | $668M | $222M | $231M | $94M | $142M | $158M | $188M | $240M | $271M | $282M | · | $301M | $245M | $276M | · | $293M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Prepaid Expense | $18M | $12M | $10M | $11M | $9M | $8M | $8M | $8M | $6M | $8M | · | $10M | $9M | $9M | · | $6M | |
| Current Assets | $1.03B | $392M | $354M | $164M | $190M | $225M | $266M | $301M | $328M | $352M | · | $371M | $321M | $343M | · | $402M | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $8M | $8M | $8M | $9M | $9M | $10M | · | $10M | $11M | $11M | · | $11M | |
| PP&E (Gross) | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | $16M | · | $16M | $16M | $15M | · | $14M | |
| Accum. Depreciation | $11M | $11M | $11M | $10M | $10M | $9M | $8M | $8M | $7M | $7M | · | $5M | $5M | $4M | · | $3M | |
| Other Non-current Assets | $312.0K | $293.0K | $303.0K | $290.0K | $310.0K | $1.0K | $4.0K | $13.0K | $10.0K | $11.0K | · | $48.0K | $12.0K | $19.0K | · | $6.0K | |
| Total Assets | $1.07B | $436M | $399M | $210M | $238M | $274M | $316M | $352M | $381M | $406M | · | $428M | $379M | $404M | · | $464M | |
| Accounts Payable | $2M | $2M | $1M | $2M | $3M | $3M | $2M | $4M | $1M | $4M | · | $3M | $5M | $6M | · | $6M | |
| Current Liabilities | $20M | $14M | $22M | $18M | $40M | $36M | $38M | $38M | $44M | $43M | · | $43M | $54M | $54M | · | $51M | |
| Capital Leases | $29M | $30M | $31M | $32M | $32M | $34M | $34M | $35M | $35M | $36M | · | $37M | $38M | $39M | · | $40M | |
| Total Liabilities | $49M | $44M | $53M | $50M | $103M | $108M | $117M | $123M | $134M | $142M | · | $152M | $166M | $177M | · | $191M | |
| Common Stock | $168.0K | $144.0K | $136.0K | $112.0K | $111.0K | $108.0K | $108.0K | $107.0K | $107.0K | $107.0K | · | $102.0K | $88.0K | $88.0K | · | $88.0K | |
| Paid-in Capital | $1.73B | $1.04B | $949M | $724M | $715M | $708M | $701M | $692M | $683M | $674M | · | $618M | $533M | $527M | · | $518M | |
| Retained Earnings | $-704M | $-649M | $-603M | $-564M | $-580M | $-541M | $-502M | $-464M | $-435M | $-409M | · | $-340M | $-318M | $-298M | · | $-240M | |
| AOCI | $-633.0K | $-115.0K | $224.0K | $121.0K | $94.0K | $194.0K | $336.0K | $750.0K | $-334.0K | $-257.0K | · | $-681.0K | $-2M | $-2M | · | $-5M | |
| Stockholders' Equity | $1.02B | $392M | $346M | $160M | $135M | $167M | $200M | $229M | $248M | $264M | $253M | $277M | $213M | $227M | $249M | $273M | |
| Liabilities + Equity | $1.07B | $436M | $399M | $210M | $238M | $274M | $316M | $352M | $381M | $406M | · | $428M | $379M | $404M | · | $464M | |
| Shares Outstanding | 168,380,091 | 144,162,543 | 135,940,454 | 111,567,062 | 110,871,249 | 108,107,890 | 107,729,343 | 107,414,636 | 107,044,240 | 106,730,785 | · | 101,847,154 | 88,462,844 | 88,209,964 | · | 88,067,254 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $11M | $6M | $7M | $7M | $7M | $7M | $7M | $8M | $7M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Operating Cash Flow | $-39M | $-44M | $-30M | $-31M | $-37M | $-42M | $-37M | $-33M | $-24M | $-38M | $-27M | $-31M | $-24M | $-35M | $-28M | $-20M | |
| CapEx | $-20.0K | $-2.0K | $222.0K | $151.0K | $624.0K | $51.0K | $124.0K | $115.0K | $320.0K | $195.0K | $226.0K | $16.0K | $664.0K | $620.0K | $1M | $3M | |
| Investing Cash Flow | $-446M | $10M | $-136M | $47M | $17M | $31M | $52M | $33M | $13M | $-11M | $34M | $-57M | $33M | $32M | $-13M | $15M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $42M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $42M | · | · | · | · | · | · | |
| Financing Cash Flow | $673M | $80M | $219M | $3M | $581.0K | $2.0K | $969.0K | $2M | $1M | $43M | $1M | $80M | $586.0K | $73.0K | $527.0K | $113.0K | |
| Net Change in Cash | $188M | $45M | $54M | $19M | $-19M | $-11M | $16M | $2M | $-10M | $-6M | $8M | $-8M | $9M | $-3M | $-40M | $-4M | |
| Free Cash Flow | · | $-44M | · | · | · | $-42M | · | · | · | $-38M | · | · | · | $-36M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | 26.2% | -1287.9% | -788.8% | · | -283.3% | -148.7% | -653.0% | · | -238.8% | -159.2% | -525.2% | · | -432.4% | |
| Net Margin | · | · | · | 29.5% | -1221.4% | -739.5% | · | -251.3% | -128.6% | -585.9% | · | -207.4% | -141.9% | -485.7% | · | -419.8% | |
| Pretax Margin | · | · | · | 29.5% | -1220.3% | -738.9% | · | -250.8% | -128.2% | -585.3% | · | -207.2% | -141.4% | · | · | -419.8% | |
| EBITDA Margin | · | · | · | 26.2% | -1287.9% | -788.8% | · | -283.3% | -148.7% | -653.0% | · | -238.8% | -159.2% | -525.2% | · | -432.4% | |
| ROA | -8.4% | -12.8% | · | 5.7% | -12.6% | -11.7% | · | -7.5% | -6.7% | -9.4% | · | -5.0% | -5.0% | -6.4% | · | -5.8% | |
| ROE | -9.6% | -16.3% | · | 8.2% | -20.3% | -18.5% | · | -11.5% | -11.1% | -15.4% | · | -8.1% | -8.1% | -10.2% | · | -9.1% | |
| ROIC | -5.8% | -12.5% | · | 8.8% | -30.4% | -25.5% | · | -14.4% | -12.0% | -16.0% | · | -9.3% | -10.9% | · | · | -11.0% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 50.8 | 27.4 | · | 8.9 | 4.7 | 6.3 | · | 8.0 | 7.5 | 8.2 | · | 8.5 | 6.0 | 6.4 | · | 7.8 | |
| Quick Ratio | 50.0 | 26.5 | · | 8.3 | 4.5 | 6.0 | · | 7.8 | 7.3 | 8.0 | · | 8.3 | 5.8 | 6.2 | · | 7.7 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 1.4 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $57M | $62M | · | $74M | $40M | $43M | · | $49M | $52M | $38M | · | $38M | $33M | $24M | · | $25M | |
| Net Income TTM | $-124M | $-108M | · | $-92M | $-133M | $-133M | · | $-115M | $-106M | $-109M | · | $-100M | $-103M | $-107M | · | $-99M | |
| Market Cap | $5.26B | $3.02B | · | $937M | $568M | $148M | · | $827M | $918M | $847M | · | $1.15B | $294M | $348M | · | $319M | |
| P/E | -34.4 | -23.2 | · | -9.9 | -4.2 | -1.1 | · | -7.1 | -8.2 | -7.0 | · | -10.1 | -2.9 | -3.2 | · | -3.1 | |
| P/S | 92.4 | 48.3 | · | 12.7 | 14.2 | 3.4 | · | 17.0 | 17.8 | 22.6 | · | 30.2 | 8.9 | 14.4 | · | 12.6 | |
| P/B | 5.1 | 7.7 | · | 5.9 | 4.2 | 0.9 | · | 3.6 | 3.7 | 3.2 | · | 4.1 | 1.4 | 1.5 | · | 1.2 | |
| P / Tangible Book | 5.1 | 7.7 | · | 5.9 | 4.2 | 0.9 | · | 3.6 | 3.7 | 3.2 | · | 4.1 | 1.4 | 1.5 | · | 1.2 | |
| P / Cash Flow | · | -68.0 | · | · | · | -3.6 | · | · | · | -22.4 | · | · | · | -10.0 | · | · | |
| P / FCF | · | -68.0 | · | · | · | -3.5 | · | · | · | -22.3 | · | · | · | -9.8 | · | · | |
| Earnings Yield | -2.9% | -4.3% | · | -10.1% | -23.8% | -89.0% | · | -14.2% | -12.2% | -14.2% | · | -9.9% | -34.9% | -30.9% | · | -32.6% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $62M | $42M | $37M | $25M | $37M |
| Betriebsgewinnmarge % | -178.4% | -346.1% | -312.6% | -446.8% | -157.1% |
| Nettoergebnis | $-102M | $-130M | $-102M | $-108M | $-58M |
| Verwässerte EPS | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 16.3 | 7.0 | 7.5 | 6.8 | 12.1 |
| Quick Ratio | 15.8 | 6.8 | 7.3 | 6.6 | 12.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-140M | $-132M | $-120M | $-117M | $-61M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 262 Einreicher · $5.3B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 84 (+30 vs. Vorquartal) | 21 (-9 vs. Vorquartal) | 92 (+28 vs. Vorquartal) | 59 (+3 vs. Vorquartal) | +34.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $434.533.381 | 13.900.620 | 8,13% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $383.779.020 | 12.277.000 | 7,18% | Aktien |
| Boxer Capital Management, LLC | $339.990.606 | 10.876.219 | 6,36% | Aktien |
| GOLDMAN SACHS GROUP INC | $301.599.366 | 9.648.092 | 5,64% | Aktien |
| TCG Crossover Management, LLC | $283.878.343 | 9.081.201 | 5,31% | Aktien |
| FMR LLC | $252.410.308 | 8.074.546 | 4,72% | Aktien |
| Paradigm Biocapital Advisors LP | $198.736.169 | 6.357.523 | 3,72% | Aktien |
| Siren, L.L.C. | $193.166.919 | 6.179.364 | 3,61% | Aktien |
| STATE STREET CORP | $186.928.736 | 5.979.806 | 3,50% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $186.226.699 | 5.957.348 | 3,48% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $175.056.000 | 5.600.000 | 3,28% | Aktien |
| Deep Track Capital, LP | $131.292.000 | 4.200.000 | 2,46% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $130.998.500 | 4.190.611 | 2,45% | Aktien |
| Woodline Partners LP | $125.057.724 | 4.000.567 | 2,34% | Aktien |
| TRV GP IV, LLC | $120.181.383 | 6.374.574 | 2,25% | Aktien |
| PERCEPTIVE ADVISORS LLC | $105.565.020 | 3.377.000 | 1,97% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $101.978.756 | 3.261.580 | 1,91% | Aktien |
| Logos Global Management LP | $89.091.000 | 2.850.000 | 1,67% | Aktien |
| Caligan Partners LP | $78.153.220 | 2.500.103 | 1,46% | Aktien |
| Holocene Advisors, LP | $75.365.953 | 2.410.939 | 1,41% | Aktien |
| Commodore Capital LP | $70.335.000 | 2.250.000 | 1,32% | Aktien |
| Balyasny Asset Management L.P. | $63.032.008 | 2.016.379 | 1,18% | Aktien |
| Jefferies Financial Group Inc. | $62.849.293 | 2.010.534 | 1,18% | Aktien |
| Seven Fleet Capital Management LP | $54.443.081 | 1.909.593 | 1,02% | Aktien |
| Candriam S.C.A. | $50.922.046 | 1.630.553 | 0,95% | Aktien |
| JANUS HENDERSON GROUP PLC | $49.579.803 | 2.371.672 | 0,93% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $49.550.570 | 1.585.111 | 0,93% | Aktien |
| Polar Capital Holdings Plc | $46.287.932 | 1.480.740 | 0,87% | Aktien |
| Vivo Capital, LLC | $43.131.579 | 1.379.769 | 0,81% | Aktien |
| DV EQUITIES, LLC | $41.217.904 | 1.318.551 | 0,77% | Aktien |
| Cormorant Asset Management, LP | $40.638.000 | 1.300.000 | 0,76% | Aktien |
| STEMPOINT CAPITAL LP | $38.231.574 | 1.223.019 | 0,72% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $33.512.564 | 1.072.059 | 0,63% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $31.691.245 | 1.013.794 | 0,59% | Aktien |
| Integral Health Asset Management, LLC | $31.260.000 | 1.000.000 | 0,58% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $28.620.562 | 915.565 | 0,54% | Aktien |
| FEDERATED HERMES, INC. | $26.956.373 | 862.328 | 0,50% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $23.391.858 | 748.300 | 0,44% | Aktien |
| Soleus Capital Management, L.P. | $22.163.340 | 709.000 | 0,41% | Aktien |
| ArrowMark Colorado Holdings LLC | $22.144.115 | 708.385 | 0,41% | Aktien |
| Bellevue Group AG | $21.700.129 | 694.182 | 0,41% | Aktien |
| Alyeska Investment Group, L.P. | $21.604.067 | 691.109 | 0,40% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $19.871.576 | 635.687 | 0,37% | Aktien |
| Pictet Asset Management Holding SA | $18.343.379 | 582.262 | 0,34% | Aktien |
| Fisher Asset Management, LLC | $18.073.218 | 578.158 | 0,34% | Aktien |
| Nextech Invest Ltd. | $17.099.998 | 5.533.980 | 0,32% | Aktien |
| FIRST TRUST ADVISORS LP | $15.920.999 | 509.309 | 0,30% | Aktien |
| Nantahala Capital Management, LLC | $15.650.600 | 500.659 | 0,29% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $15.645.536 | 500.497 | 0,29% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $15.506.085 | 496.036 | 0,29% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $14.536.650 | 465.024 | 0,27% | Aktien |
| Rock Springs Capital Management LP | $14.271.784 | 456.551 | 0,27% | Aktien |
| BOONE CAPITAL MANAGEMENT LLC | $14.242.212 | 455.605 | 0,27% | Aktien |
| Longaeva Partners L.P. | $12.969.837 | 414.902 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $12.604.469 | 403.214 | 0,24% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $12.504.000 | 400.000 | 0,23% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $12.221.066 | 390.949 | 0,23% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $11.902.120 | 380.746 | 0,22% | Aktien |
| Mass General Brigham, Inc | $11.072.042 | 354.192 | 0,21% | Aktien |
| Assenagon Asset Management S.A. | $10.789.577 | 345.156 | 0,20% | Aktien |
| BAKER BROS. ADVISORS LP | $10.419.990 | 333.333 | 0,19% | Aktien |
| PFM Health Sciences, LP | $10.192.229 | 326.047 | 0,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $9.576.345 | 306.345 | 0,18% | Aktien |
| JANE STREET GROUP, LLC | $9.354.993 | 299.264 | 0,18% | Aktien |
| Point72 Asset Management, L.P. | $9.326.077 | 298.339 | 0,17% | Aktien |
| SAMLYN CAPITAL, LLC | $9.145.519 | 292.563 | 0,17% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9.068.318 | 278.511 | 0,17% | Aktien |
| ALGERT GLOBAL LLC | $8.489.278 | 271.570 | 0,16% | Aktien |
| HighVista Strategies LLC | $8.129.788 | 260.070 | 0,15% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $7.947.855 | 254.250 | 0,15% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.558.137 | 241.783 | 0,14% | Aktien |
| KVP Capital Advisors, LP | $7.198.053 | 230.264 | 0,13% | Aktien |
| TD Asset Management Inc | $6.938.720 | 221.968 | 0,13% | Aktien |
| BlackRock, Inc. | $6.844.940 | 218.968 | 0,13% | Aktien |
| Sio Capital Management, LLC | $6.517.710 | 208.500 | 0,12% | Aktien |
| Atle Fund Management AB | $6.206.891 | 198.557 | 0,12% | Aktien |
| TRV GP VI, LLC | $6.069.879 | 194.174 | 0,11% | Aktien |
| Walleye Capital LLC | $6.010.360 | 192.270 | 0,11% | Aktien |
| Swiss National Bank | $5.858.124 | 187.400 | 0,11% | Aktien |
| VANGUARD GROUP INC | $5.714.806 | 645.012 | 0,11% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $5.664.687 | 181.212 | 0,11% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $5.525.142 | 176.748 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $5.474.643 | 175.133 | 0,10% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $4.897.973 | 156.685 | 0,09% | Aktien |
| Burkehill Global Management, LP | $4.689.000 | 150.000 | 0,09% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $4.689.000 | 150.000 | 0,09% | Aktien |
| Ghisallo Capital Management LLC | $4.689.000 | 150.000 | 0,09% | Aktien |
| CITIGROUP INC | $4.497.626 | 143.878 | 0,08% | Aktien |
| Informed Momentum Co LLC | $4.189.278 | 134.014 | 0,08% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.888.744 | 124.400 | 0,07% | Kaufoption |
| XTX Topco Ltd | $3.697.589 | 118.285 | 0,07% | Aktien |
| PRUDENTIAL FINANCIAL INC | $3.622.565 | 115.885 | 0,07% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $3.347.409 | 160.010 | 0,06% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.313.091 | 105.985 | 0,06% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $3.161.042 | 101.121 | 0,06% | Aktien |
| Monashee Investment Management LLC | $3.126.000 | 100.000 | 0,06% | Aktien |
| Balyasny Asset Management L.P. | $3.126.000 | 100.000 | 0,06% | Kaufoption |
| ExodusPoint Capital Management, LP | $3.063.949 | 98.015 | 0,06% | Aktien |
| CITADEL ADVISORS LLC | $2.991.582 | 95.700 | 0,06% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.935.314 | 93.900 | 0,05% | Verkaufsoption |
Unternehmensinsider 20 Insider · 7 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Malte Peters | President & CEO | 8. Januar 2026 A | 367.500 | 0 | 0 | $0 |
| Matthew Gall | Chief Financial Officer | 1. Mai 2026 A | 40.000 | 0 | 0 | $0 |
| Daniella Beckman | Chief Financial Officer | 2. Februar 2026 A | 184.297 | 0 | 2 | $-126.559 |
| Barbara Weber | Director, Executive Chair | 2. Februar 2026 A | 1.629.254 | 0 | 2 | $-374.376 |
| Douglas Barry | General Counsel | 5. Februar 2025 S | 66.014 | 0 | 0 | $0 |
| Alan Huang | Chief Scientific Officer | 1. März 2023 A | 167.584 | 0 | 0 | $0 |
| Marc Rudoltz | Chief Medical Officer | 1. November 2021 A | — | 0 | 0 | $0 |
| Robert Azelby | Direktor | 19. Juni 2026 A | 5.740 | 0 | 0 | $0 |
| John B Ketchum | Direktor | 5. Juni 2026 A | 24.937 | 0 | 0 | $0 |
| Mace Rothenberg | Direktor | 5. Juni 2026 A | 41.500 | 0 | 0 | $0 |
| Sung Lee | Direktor | 5. Juni 2026 A | 22.870 | 0 | 0 | $0 |
| Lesley Ann Calhoun | Direktor | 5. Juni 2026 A | 16.500 | 0 | 0 | $0 |
| Alexis Borisy | Direktor | 5. Juni 2025 A | 17.500 | 0 | 0 | $0 |
| Reid M Huber | Direktor | 6. Juni 2023 A | 5.000 | 0 | 0 | $0 |
| Tango Therapeutics, Inc. | Direktor | 8. Dezember 2021 A | 3.400 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10%-Eigentümer | 7. November 2024 S | 10.630.736 | 0 | 0 | $0 |
| Adam Crystal | — | 3. August 2026 M | 115.743 | 0 | 15 | $-5.724.378 |
| Davis Aaron I. | — | 3. September 2024 J | 5.000 | 0 | 0 | $0 |
| Aaron Weitzman | — | 1. Dezember 2022 A | — | 0 | 0 | $0 |
| BCTG Holdings, LLC | — | 20. November 2020 S | 4.488.450 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Third Rock Ventures IV, L.P., Third Rock Ventures GP IV, L.P., TRV GP IV, LLC ×3 Einreichungen | 10. Februar 2026 | 4,74% | Änderung | — | SEC |
| BCTG Holdings, LLC, MVA Investors, LLC, Davis Aaron I., Boxer Capital Management, LLC ×7 Einreichungen | 2. Januar 2025 | 10,00% | Änderung | — | SEC |
| Boxer Asset Management Inc., Braslyn Ltd., Joe Lewis | 15. Oktober 2024 | — | Erste Einreichung | — | SEC |
| Boxer Capital Management, LLC, Boxer Capital, LLC, MVA Investors, LLC, Aaron I. Davis | 15. Oktober 2024 | — | Erste Einreichung | — | SEC |
| Third Rock Ventures IV, L.P. (2), Third Rock Ventures GP IV, L.P. (2), TRV GP IV, LLC (2) ×2 Einreichungen | 4. September 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 40 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2,07% | 188.550 SH | 8. August 2026 | Täglich |
| BBC · ETFis Series Trust I | 1,71% | 29.518 NS | 30. April 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,26% | 208.730 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,58% | 278.656 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,47% | 112.975 NS | 30. April 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,30% | 165.931 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,27% | 877.490 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,27% | 7.871 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,26% | 150.730 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,25% | 1.280.778 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,23% | 146.692 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,15% | 4.978 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,13% | 810.623 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,13% | 3.593.320 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,12% | 25.999 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,09% | 29.437 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,07% | 48.104 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,07% | 32.613 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,07% | 75.650 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,07% | 65.532 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,06% | 5.226 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 471.380 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 4.243 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.418.754 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 281.272 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,04% | 4.088 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 6.197 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,03% | 4.138 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 20.381 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3.996 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 104 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 4.396.603 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.571 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 61.068 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 36.046 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 39.761 SH | 8. August 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 151.725 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 60.195 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.480 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 5.276 NS | 30. April 2026 | N-PORT |